http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CS-258294-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5baa2ef842bf27d92e8ec825818d51c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8095fcbc14f32f140efa46074f127f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_978ccf40444ebfc44eb9220436a527d1
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-12
filingDate 1987-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d194104df47030c5aa3874f35e54eac0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e994d4860ad676ecdd0c051abe160686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ec87222c3849844318ae37fe2ffa6be
publicationDate 1988-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CS-258294-B1
titleOfInvention Process for the preparation of pure 1- (tetrahydro-2-furyl) -3- (1-naphthyl) propane-2,2-dicarboxylic acid
abstract The solution lies in the field of drug synthesis.nIts object is a clean preparation methodn1- (tetrahydro-2-furyl) -3- (1-naphthyl) -npropane-2,2-dicarboxylic acid (I), which is an intermediatenthe manufacture of medicaments, especially cerebral agentsnvasodilating activity. Waynpreparation of the substance according to this solution liesnin the hydrolysis of 1- (tetrahydro-2-furyl) -3- (1-naphthyl) propane-2,2-dicarboxylic acid diethyl esternaqueous alcoholic hydroxidenpotassium, followed by removal of ethanolndistillation, crystalline exclusionndipotassium salt of acid I by addition of a solutionnof potassium chloride, in Isolation of thisnsalt and its purification by recrystallization,nin the subsequent decomposition of the salt with an acidnhydrochloric acid, released in isolationnacid I by extraction with dichloromethane and crystallizationnfrom this solvent. Usage ^npure acid I as an intermediatendeletion of demanding distillations as a starting distillationnester, as well as other substances, from the acidnI prepared.
priorityDate 1987-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415817713
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414860055
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453569306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76419195
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11834831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501979
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410697574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426210715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14374334
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4417
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448886471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411471814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426563542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414977813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3716971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158135166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID117180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454620584

Total number of triples: 45.